Search Results - "Whyte, Lauren S."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Endo‐lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease? by Whyte, Lauren S., Lau, Adeline A., Hemsley, Kim M., Hopwood, John J., Sargeant, Timothy J.

    Published in Journal of neurochemistry (01-03-2017)
    “…Alzheimer's disease (AD) is the most common cause of dementia, and its prevalence will increase significantly in the coming decades. Although important…”
    Get full text
    Journal Article
  2. 2

    putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo by Whyte, Lauren S, Ryberg, Erik, Sims, Natalie A, Ridge, Susan A, Mackie, Ken, Greasley, Peter J, Ross, Ruth A, Rogers, Michael J

    “…GPR55 is a G protein-coupled receptor recently shown to be activated by certain cannabinoids and by lysophosphatidylinositol (LPI). However, the physiological…”
    Get full text
    Journal Article
  3. 3

    Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology by Morales, Paula, Whyte, Lauren S, Chicharro, Roberto, Gómez-Cañas, María, Pazos, M. Ruth, Goya, Pilar, Irving, Andrew J, Fernández-Ruiz, Javier, Ross, Ruth A, Jagerovic, Nadine

    Published in Journal of medicinal chemistry (10-03-2016)
    “…The orphan G protein-coupled receptor GPR55 has been proposed as a novel receptor of the endocannabinoid system. However, the validity of this categorization…”
    Get full text
    Journal Article
  4. 4

    Reduction in open field activity in the absence of memory deficits in the AppNL−G−F knock-in mouse model of Alzheimer’s disease by Whyte, Lauren S., Hemsley, Kim M., Lau, Adeline A., Hassiotis, Sofia, Saito, Takashi, Saido, Takaomi C., Hopwood, John J., Sargeant, Timothy J.

    Published in Behavioural brain research (15-01-2018)
    “…•AppNL−G−F mice show reduced open field activity at six months of age.•Detection of memory deficits in six month AppNL−G−F mice may depend on…”
    Get full text
    Journal Article
  5. 5

    Lysosomal gene Hexb displays haploinsufficiency in a knock-in mouse model of Alzheimer’s disease by Whyte, Lauren S., Fourrier, Célia, Hassiotis, Sofia, Lau, Adeline A., Trim, Paul J., Hein, Leanne K., Hattersley, Kathryn J., Bensalem, Julien, Hopwood, John J., Hemsley, Kim M., Sargeant, Timothy J.

    Published in IBRO neuroscience reports (01-06-2022)
    “…Lysosomal network abnormalities are an increasingly recognised feature of Alzheimer’s disease (AD), which appear early and are progressive in nature. Sandhoff…”
    Get full text
    Journal Article
  6. 6

    Variables influencing fluorimetric N-sulfoglucosamine sulfohydrolase (SGSH) activity measurement in brain homogenates by Whyte, Lauren S., Hopwood, John J., Hemsley, Kim M., Lau, Adeline A.

    Published in Molecular genetics and metabolism reports (01-12-2015)
    “…Deficient N-sulfoglucosamine sulfohydrolase (SGSH) enzyme activity causes mucopolysaccharidosis (MPS) type IIIA. A fluorimetric SGSH activity assay is commonly…”
    Get full text
    Journal Article
  7. 7

    Lysosomal Dysregulation in the Murine AppNL-G-F/NL-G-F Model of Alzheimer’s Disease by Whyte, Lauren S., Hassiotis, Sofia, Hattersley, Kathryn J., Hemsley, Kim M., Hopwood, John J., Lau, Adeline A., Sargeant, Timothy J.

    Published in Neuroscience (01-03-2020)
    “…•LAMP1 accumulates at amyloid beta plaques in AppNL-G-F/NL-G-F (knock-in) mouse brain.•Lysosomal hydrolases are enriched at amyloid beta plaques in…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome by Lau, Adeline A., King, Barbara M., Thorsen, Carly L., Hassiotis, Sofia, Beard, Helen, Trim, Paul J., Whyte, Lauren S., Tamang, Sarah J., Duplock, Stephen K., Snel, Marten F., Hopwood, John J., Hemsley, Kim M.

    Published in Journal of inherited metabolic disease (01-09-2017)
    “…Mucopolysaccharidosis (MPS) type IIIA, or Sanfilippo syndrome, is a neurodegenerative lysosomal storage disorder caused by a deficiency of the lysosomal enzyme…”
    Get full text
    Journal Article
  10. 10

    Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro by Whyte, LS, Ford, L, Ridge, SA, Cameron, GA, Rogers, MJ, Ross, RA

    Published in British journal of pharmacology (01-04-2012)
    “…BACKGROUND AND PURPOSE Both CB1 and CB2 cannabinoid receptors have been shown to play a role in bone metabolism. Crucially, previous studies have focussed on…”
    Get full text
    Journal Article
  11. 11

    Lysosomal Dysregulation in the Murine App NL-G-F/NL-G-F Model of Alzheimer's Disease by Whyte, Lauren S, Hassiotis, Sofia, Hattersley, Kathryn J, Hemsley, Kim M, Hopwood, John J, Lau, Adeline A, Sargeant, Timothy J

    Published in Neuroscience (01-03-2020)
    “…Lysosomal network dysfunction is a prominent feature of Alzheimer's disease (AD). Although transgenic mouse models of AD are known to model some aspects of…”
    Get full text
    Journal Article
  12. 12

    Reduction in open field activity in the absence of memory deficits in the App NL-G-F knock-in mouse model of Alzheimer's disease by Whyte, Lauren S, Hemsley, Kim M, Lau, Adeline A, Hassiotis, Sofia, Saito, Takashi, Saido, Takaomi C, Hopwood, John J, Sargeant, Timothy J

    Published in Behavioural brain research (15-01-2018)
    “…The recent development of knock-in mouse models of Alzheimer's disease provides distinct advantages over traditional transgenic mouse models that rely on…”
    Get full text
    Journal Article